The early clinical research of the research group showed that XFPC capsules significantly improved AMH symptoms such as cough and expectoration in COPD patients compared with modern medicine treatment control group (Wang et al., 2016; Xue et al., 2012). Here, AMH is linked to chronic obstructive pulmonary disease.